title: Reply: Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
authors.forename: Yaling
authors.initials: Y
authors.lastname: Han
mesh_terms: D058186:Acute Kidney Injury / Q000517:prevention & control*; D000792:Angiography / Q000009:adverse effects*; D003287:Contrast Media / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D003287:Contrast Media; D005464:Fluorobenzenes; D011743:Pyrimidines; D013449:Sulfonamides